Artificial intelligence can be said to be ubiquitous, and the health care sector is no exception. Having said that, since the regulatory approval mechanism has not evolved with the times, it is necessary to apply artificial intelligence to the health care field to make the most of it. Zebra Medical Vision provides a deep learning image analysis platform for the medical industry . The company announced today that its coronary artery calcification algorithm has been licensed by the FDA 510(k). This is a major step forward for this Israeli company. The company raised $30 million in June to promote its products in the US market. Zebra's technology accurately captures misdiagnosed diseases, early cancers, and other diseases that threaten human life through artificial intelligence algorithms. With millions of high-quality scans, Zebra has created a deep learning engine that automatically detects liver, lung, cardiovascular and bone diseases. Last year, the company made a major decision to announce that it only cost $1 per scan. Therefore, all hospitals can use this technology. Although Zebra Medical Vision has a variety of algorithms for detecting a variety of conditions, today's statement focuses on the detection of coronary artery disease (CAD). Coronary heart disease is a leading cause of death. In fact, in the United States, the number of deaths caused by coronary heart disease is very high, and it has exceeded the sum of the deaths caused by the other seven diseases. Numerous studies have shown that early detection and treatment of coronary heart disease can effectively reduce the incidence of heart disease in high-risk groups. Dr. Ran Balicer, director of the Clalit Research Institute, a health data analysis organization, said: "Identifying high-risk populations is the key to prevention. Zebra's algorithm can be applied to chest CT and can help identify people at risk of cardiovascular disease earlier, and thus more Effectively treats diseases and alleviates adverse effects, while also reducing the overall cost of health care organizations such as Clalit (HMOs)." The company's statement today indicates that they are one step closer to the approval of all Zebra-developed artificial intelligence inspection systems. “This license will enable us to continue to expand our business in the US,†said Elad Benjamin, co-founder and CEO of Zebra Medical Vision. “The process of building our automated analysis engine. In the middle, we already have 7 algorithms that carry CE Mark (a safety sign that must be carried in 28 European countries), and there are many algorithms to meet you in the future. This coronary calcification scoring algorithm will be our first step. †Hidden Safe Box,Bedroom Safe Box,Intelligent Safe Box,Cash Box Hebei Yingbo Safe Boxes Co.,Ltd , https://www.ybsafebox.com